INP54 Antibody

What is INP54 and why is it significant in cellular research?

INP54 is one of four inositol polyphosphate 5-phosphatase genes in budding yeast Saccharomyces cerevisiae, along with INP51, INP52, and INP53. All of these phosphatases hydrolyze phosphatidylinositol (4,5)-bisphosphate . INP54 encodes a 44 kDa protein with a unique structure consisting of only a 5-phosphatase domain and a C-terminal leucine-rich tail, notably lacking the N-terminal SacI domain and proline-rich region found in the other yeast 5-phosphatases . The protein plays a significant role in regulating secretion, likely by modulating the levels of phosphatidylinositol (4,5)-bisphosphate on the cytoplasmic surface of the endoplasmic reticulum membrane . Research on INP54 provides insights into phosphoinositide signaling, membrane trafficking, and protein secretion mechanisms in eukaryotic cells.

How is INP54 protein structurally organized and localized in yeast cells?

INP54 protein belongs to the family of tail-anchored proteins and is specifically localized to the endoplasmic reticulum via its C-terminal hydrophobic tail . This hydrophobic tail comprises the last 13 amino acids of the protein and is sufficient to target green fluorescent protein to the endoplasmic reticulum when used as a fusion tag . Protease protection assays have demonstrated that the N-terminus of INP54 is oriented toward the cytoplasm of the cell, with the C-terminus of the protein also exposed to the cytosol . This topology is crucial for its function in modulating phosphoinositide levels at the ER-cytosol interface.

How does INP54 compare structurally to other inositol phosphatases in yeast?

The structural comparison between yeast inositol phosphatases reveals important differences:

INP54's simpler domain architecture compared to other phosphatases suggests a more specialized function, particularly in secretory regulation at the ER membrane .

What are the best methods for detecting endogenous INP54 in yeast samples?

For detecting endogenous INP54 in yeast samples, several approaches are recommended:

• Western blotting with specific anti-INP54 antibodies remains the gold standard for quantitative detection. When performing this technique, researchers should use appropriate extraction buffers that efficiently solubilize membrane proteins, as INP54 is a tail-anchored ER membrane protein . For validation, comparing wild-type yeast with inp54Δ mutant strains is essential to confirm antibody specificity.

• Immunofluorescence microscopy can reveal the subcellular localization of INP54, typically showing ER membrane patterns. This approach requires careful fixation and permeabilization protocols that preserve membrane structures while allowing antibody access to epitopes.

• For comparative studies, researchers can use epitope-tagged versions of INP54 (with N-terminal tags to avoid disrupting the C-terminal membrane anchor) coupled with standard anti-epitope antibodies.

When using commercially available antibodies such as the CSB-PA781924XA01SVG for S. cerevisiae, preliminary validation experiments are recommended to confirm specificity in your specific yeast strain and experimental conditions .

What controls should be included when validating an INP54 antibody?

Rigorous validation of INP54 antibodies should include the following controls:

• Genetic controls: The primary validation should compare antibody reactivity between wild-type yeast and inp54Δ strains. A specific antibody will show a clear signal at the expected molecular weight (44 kDa) in wild-type samples and no signal in the deletion strain.

• Epitope competition: Pre-incubating the antibody with excess immunizing peptide (if available) should abolish specific binding in western blots and immunofluorescence.

• Cross-reactivity assessment: Testing the antibody against other yeast 5-phosphatases (Inp51p, Inp52p, Inp53p) is crucial to ensure it doesn't recognize conserved domains shared among these proteins.

• Cellular localization confirmation: In immunofluorescence experiments, INP54 should co-localize with established ER markers and show the expected membrane pattern consistent with its known ER localization.

• Positive controls: Including samples with overexpressed INP54 can help establish the signal range and confirm the molecular weight.

What sample preparation methods are optimal for INP54 antibody applications?

The membrane-associated nature of INP54 requires specific sample preparation considerations:

• For western blotting: The post-alkaline lysis method has proven effective for yeast protein extraction when studying membrane proteins like INP54 . This approach helps maintain protein integrity while efficiently extracting membrane-associated proteins. Include membrane solubilization detergents (such as 1% Triton X-100 or 0.5% CHAPS) in your lysis buffer.

• For immunoprecipitation: Gentler extraction conditions with milder detergents (0.5% digitonin or 0.3% CHAPS) can help preserve protein-protein interactions while solubilizing INP54 from membranes.

• For immunofluorescence: A combination of formaldehyde fixation (3-4%) with minimal permeabilization (0.1% Triton X-100) helps preserve the ER membrane structure while allowing antibody access to INP54 epitopes.

• Subcellular fractionation: When studying INP54's membrane association, differential centrifugation followed by western blotting can confirm its enrichment in ER membrane fractions versus cytosolic fractions.

Including protease inhibitors in all buffers is essential to prevent degradation of INP54 during sample preparation.

How can INP54 antibodies be used effectively for subcellular localization studies?

For optimal subcellular localization studies of INP54:

• Sample preparation: Fix yeast cells with 4% paraformaldehyde for 30 minutes, followed by spheroplasting with zymolyase and gentle permeabilization with 0.1% Triton X-100 to maintain membrane integrity while allowing antibody access.

• Co-localization approach: Perform double immunofluorescence with INP54 antibodies and established ER markers (like Kar2p/BiP in yeast). This confirms the specific ER localization of INP54 and can reveal whether it localizes to particular ER subdomains.

• Controls: Include inp54Δ strains as negative controls and N-terminally GFP-tagged INP54 as positive controls to validate antibody specificity and localization patterns.

• Imaging optimization: Use deconvolution microscopy or confocal microscopy to capture clear images of the ER membrane distribution. Taking optical z-sections through the middle and periphery of yeast cells helps visualize the complete ER network .

• Quantitative analysis: Measure co-localization coefficients between INP54 staining and ER markers to provide objective data on localization specificity.

Research has shown that INP54 localizes specifically to the endoplasmic reticulum through its C-terminal hydrophobic tail, with both the N-terminus and C-terminus oriented toward the cytoplasm .

What experimental approaches can determine INP54's role in phosphoinositide metabolism?

To investigate INP54's specific role in phosphoinositide metabolism:

• Phosphoinositide measurement: Use thin-layer chromatography or mass spectrometry to quantify PtdIns(4,5)P₂ levels in wild-type versus inp54Δ strains. Focus specifically on ER membrane fractions to detect local changes that might be missed in whole-cell analyses.

• Phosphoinositide visualization: Express fluorescent PtdIns(4,5)P₂ biosensors (such as PH domain-GFP fusions) in wild-type and inp54Δ strains to visualize changes in phosphoinositide distribution in vivo.

• In vitro phosphatase assays: Immunoprecipitate INP54 using specific antibodies and measure its 5-phosphatase activity against PtdIns(4,5)P₂ substrates to confirm its enzymatic function and identify regulatory factors.

• Epistasis experiments: Combine inp54Δ with mutations in phosphoinositide kinases (like Stt4p or Mss4p) to determine pathway relationships and functional hierarchies.

• Secretion phenotype correlation: Measure the 2-fold increase in secretion observed in inp54Δ strains while simultaneously monitoring PtdIns(4,5)P₂ levels to establish direct correlation between phosphoinositide metabolism and secretory phenotypes .

These approaches can help determine whether INP54's effects on secretion are directly mediated through changes in phosphoinositide levels at the ER membrane.

How can researchers differentiate between specific INP54 effects and general phosphoinositide pathway disruption?

Distinguishing specific INP54 effects from general phosphoinositide pathway disruptions requires carefully designed experiments:

• Comparative mutant analysis: Compare phenotypes between inp54Δ and other phosphoinositide phosphatase mutants (inp51Δ, inp52Δ, inp53Δ). Research shows that only inp54Δ exhibits a 2-fold increase in secretion of reporter proteins, suggesting a specific role rather than a general phosphoinositide imbalance effect .

• Domain swap experiments: Create chimeric proteins with the 5-phosphatase domain of INP54 fused to localization signals from other phosphatases to determine if the phenotype is due to the specific activity of INP54 or its unique ER localization.

• Substrate specificity: Test whether INP54's ability to hydrolyze PtdIns(4,5)P₂ is specific to this substrate or extends to other phosphoinositides by using purified protein in in vitro assays with various substrates.

• Rescue experiments: Express wild-type INP54 or catalytically inactive mutants in inp54Δ strains to determine if the phosphatase activity is specifically required for complementing the secretion phenotype.

• Targeted inhibition: Use specific inhibitors of different phosphoinositide pathways and compare their effects to inp54Δ phenotypes to identify unique versus overlapping functions.

How can INP54 antibodies be used for studying protein-protein interactions?

INP54 antibodies can facilitate several protein-protein interaction studies through these methodological approaches:

• Co-immunoprecipitation (Co-IP): Use INP54 antibodies to pull down INP54 complexes from yeast lysates prepared with membrane-preserving detergents (0.5% digitonin or 0.3% CHAPS). Follow with mass spectrometry or western blotting to identify interacting partners. This approach has revealed interactions between phosphoinositide-metabolizing enzymes and trafficking machinery components.

• Proximity labeling: Coupling INP54 antibodies with biotinylation proximity assays can identify proteins in the immediate vicinity of INP54 at the ER membrane. This technique is particularly useful for identifying transient or weak interactions that might be disrupted during traditional co-IP approaches.

• Immunofluorescence co-localization: Double immunostaining with INP54 antibodies and antibodies against potential interacting proteins can provide initial evidence for interactions, particularly for proteins that co-localize at specialized ER subdomains.

• Pull-down validation: After identifying potential interactors, perform reciprocal immunoprecipitations with antibodies against the interacting partners to confirm the interactions from both directions.

When designing these experiments, consider using mild solubilization conditions and include appropriate controls such as inp54Δ strains and isotype-matched control antibodies to confirm specificity.

What experimental designs can reveal INP54's role in ER-to-Golgi trafficking?

To investigate INP54's specific role in ER-to-Golgi trafficking:

• Cargo trafficking assays: Monitor the trafficking kinetics of well-characterized secretory proteins (such as carboxypeptidase Y) in wild-type versus inp54Δ strains using pulse-chase experiments followed by immunoprecipitation. The reported 2-fold increase in secretion in inp54Δ strains suggests accelerated trafficking or reduced quality control .

• COPII vesicle formation analysis: Examine whether INP54 affects the recruitment of COPII coat components to ER exit sites using biochemical fractionation and immunofluorescence with antibodies against COPII proteins (like Sec23p or Sec31p).

• In vitro vesicle budding assays: Use microsomal preparations from wild-type and inp54Δ strains to compare the efficiency of ER-derived vesicle formation in the presence of cytosol and ATP.

• Genetic interaction analysis: Test for genetic interactions between INP54 and established ER-to-Golgi trafficking components like EMP24, ERV14, and ERV25, which function as cargo receptors in COPII vesicles .

• PtdIns(4,5)P₂ manipulation: Use acute depletion or elevation of PtdIns(4,5)P₂ levels (through rapamycin-inducible systems targeting phosphoinositide kinases or phosphatases) to determine if phosphoinositide dynamics directly influence vesicle formation rates.

How might INP54 antibodies be used in phosphoinositide signaling network analysis?

For comprehensive analysis of INP54's role in phosphoinositide signaling networks:

• Phosphoinositide interactome mapping: Use INP54 antibodies to immunoprecipitate INP54 complexes, followed by mass spectrometry to identify proteins that interact with INP54 under different cellular conditions. This can reveal condition-specific regulatory mechanisms.

• Pathway perturbation analysis: Compare phosphoproteomic profiles between wild-type and inp54Δ strains to identify signaling pathways affected by altered PtdIns(4,5)P₂ levels at the ER membrane.

• Multi-phosphatase comparison: Perform parallel immunoprecipitations of all four yeast inositol phosphatases (using specific antibodies for each) to identify shared versus unique interacting partners, helping define their specialized functions.

• Temporal dynamics studies: Use INP54 antibodies in time-course experiments following stimulation of secretory activity to determine how INP54 complexes and activities change during active secretion versus basal conditions.

• Membrane microdomain analysis: Combine detergent-resistant membrane fractionation with INP54 immunodetection to determine if INP54 localizes to specialized ER membrane domains with distinct lipid and protein compositions.

This comprehensive approach can position INP54 within the broader phosphoinositide signaling network and reveal how this specialized phosphatase contributes to membrane identity and trafficking dynamics.

What are common challenges in detecting INP54 in yeast samples and how can they be addressed?

Researchers often encounter several technical challenges when detecting INP54:

• Low abundance: INP54 may be expressed at relatively low levels in yeast cells, making detection challenging. Solution: Use enhanced chemiluminescence (ECL) substrates with higher sensitivity for western blots and consider signal amplification systems for immunofluorescence.

• Membrane extraction efficiency: As a tail-anchored membrane protein, INP54 can be difficult to extract completely. Solution: Optimize detergent concentration and extraction conditions specifically for membrane proteins. The post-alkaline lysis method has been successfully used for yeast membrane protein extraction .

• Cross-reactivity with other phosphatases: The conserved 5-phosphatase domain may lead to antibody cross-reactivity. Solution: Perform validation using inp54Δ strains and consider using antibodies raised against unique regions rather than the catalytic domain.

• Background in immunofluorescence: Yeast cell walls can trap antibodies, leading to high background. Solution: Optimize spheroplasting conditions, use longer blocking times (2-3 hours) with higher BSA concentrations (3-5%), and include multiple washing steps.

• Protein degradation during sample preparation: INP54 may be susceptible to proteolysis. Solution: Use fresh samples, keep them cold throughout preparation, and include a complete protease inhibitor cocktail in all buffers.

For western blotting applications, researchers have successfully detected INP54 as a single band at approximately 44 kDa using anti-INP54 antibodies, with phosphoglycerate kinase (PGK) serving as an effective loading control .

What alternative approaches can complement INP54 antibody-based experiments?

When INP54 antibodies present limitations or additional validation is needed:

• Epitope tagging strategies: Generate N-terminally tagged versions of INP54 (avoid C-terminal tags as they would disrupt the ER-targeting sequence). GFP-INP54 fusions have been successfully used to visualize localization . When using this approach, validate that the tagged protein maintains normal localization and function.

• Genetic approaches: Use inp54Δ strains to study loss-of-function phenotypes. The reported 2-fold increase in secretion provides a quantifiable phenotype that can be measured using reporter proteins .

• Phosphoinositide sensors: Express fluorescent PtdIns(4,5)P₂-binding domains to visualize changes in phosphoinositide distribution in living cells as an indirect measure of INP54 activity.

• Enzymatic assays: Measure 5-phosphatase activity in membrane fractions from wild-type versus inp54Δ strains as a functional readout of INP54 activity.

• Lipidomic analysis: Use mass spectrometry to directly quantify changes in phosphoinositide levels in specific membrane fractions from wild-type versus inp54Δ strains.

These complementary approaches can provide validation of antibody-based findings and offer additional insights into INP54 function when antibody limitations are encountered.

How can researchers distinguish between closely related phosphoinositide phosphatases in experimental samples?

Distinguishing between the four yeast inositol phosphatases requires careful experimental design:

• Antibody selection: Choose antibodies raised against unique regions rather than conserved domains. The C-terminal tail of INP54 differs significantly from other phosphatases and makes an ideal target for specific antibody generation.

• Size-based discrimination: On western blots, INP54 (44 kDa) can be distinguished from the larger INP51, INP52, and INP53 proteins based on molecular weight differences.

• Subcellular localization: Use immunofluorescence to distinguish INP54 (ER-localized) from other phosphatases that localize to different cellular compartments.

• Genetic controls: Always include samples from strains with individual phosphatase gene deletions to confirm antibody specificity.

• Domain-specific functional assays: INP54 lacks the SacI domain present in the other three phosphatases, allowing for discrimination based on substrate specificity in enzymatic assays.

• Expression analysis: Quantitative PCR can be used to monitor transcript levels of each phosphatase gene, providing context for protein-level observations.

By combining these approaches, researchers can reliably distinguish INP54 from related phosphatases and accurately interpret experimental results in the context of phosphoinositide signaling networks.

What emerging technologies might enhance INP54 research in the coming years?

Several emerging technologies show promise for advancing INP54 research:

• CRISPR-based approaches in yeast: Precise genome editing allows for endogenous tagging of INP54 and creation of conditional alleles that can overcome limitations of conventional deletion strategies.

• Advanced imaging techniques: Super-resolution microscopy and single-molecule tracking could reveal how INP54 is distributed within the ER membrane and whether it forms functional clusters or associates with specific membrane subdomains.

• Optogenetic tools: Light-controlled activation or inhibition of INP54 activity could enable spatiotemporal studies of phosphoinositide dynamics and their immediate effects on secretory functions.

• Proximity labeling methods: Technologies like BioID or TurboID fused to INP54 could identify proteins in its immediate vicinity without requiring stable interactions, potentially revealing transient regulatory partners.

• Cryo-electron tomography: This technique could reveal the 3D organization of INP54 within the ER membrane context at near-atomic resolution, providing structural insights into its membrane association and potential oligomerization.

These technologies could help address fundamental questions about how INP54 contributes to phosphoinositide homeostasis at the ER membrane and influences secretory pathway function.

What unresolved questions remain regarding INP54's role in cellular physiology?

Several key questions about INP54 remain to be fully addressed:

• Regulatory mechanisms: How is INP54 activity regulated in response to cellular signals or stress conditions? Are there post-translational modifications that modulate its function?

• Substrate specificity in vivo: While INP54 can hydrolyze PtdIns(4,5)P₂ in vitro, what is its preferred substrate in the cellular context, and are there additional substrates yet to be identified?

• ER subdomain specificity: Does INP54 localize uniformly throughout the ER or concentrate at specific subdomains such as ER exit sites or ER-Golgi contact sites?

• Conservation and evolution: How do INP54 homologs in other species compare functionally, and has this pathway been conserved or repurposed during evolution?

• Integration with other phosphoinositide pathways: How does INP54 activity coordinate with other phosphoinositide-metabolizing enzymes to maintain membrane identity and function?

• Physiological significance: Beyond the observed 2-fold increase in secretion, what are the broader physiological consequences of INP54 dysfunction for cellular homeostasis and stress responses?

Addressing these questions will require integrated approaches combining biochemistry, genetics, cell biology, and systems-level analyses to fully understand INP54's place in the complex landscape of cellular regulation.

How might INP54 research translate to broader understanding of phosphoinositide signaling across species?

INP54 research in yeast has significant implications for understanding phosphoinositide signaling across species:

• Conserved mechanisms: The fundamental roles of phosphoinositides in membrane identity and trafficking are conserved from yeast to humans. Insights from INP54 studies can inform our understanding of homologous pathways in higher eukaryotes.

• Disease relevance: Several human diseases involve disruptions in phosphoinositide metabolism. Understanding the basic mechanisms through yeast models provides valuable insights that might translate to therapeutic approaches.

• Evolutionary adaptations: Comparing INP54 function with related phosphatases across species can reveal how phosphoinositide signaling networks have adapted to different cellular architectures and physiological demands.

• Technological transfer: Methodologies developed for studying INP54 in yeast, including specific antibodies and biosensors, can often be adapted for use in more complex eukaryotic systems.

• Systems biology frameworks: The relatively simple yeast system allows for comprehensive analysis of phosphoinositide networks, creating conceptual frameworks that can guide studies in more complex organisms.

By continuing to investigate the fundamental mechanisms of INP54 function in yeast, researchers can establish principles that inform our broader understanding of phosphoinositide signaling across the evolutionary spectrum, ultimately contributing to both basic science knowledge and potential biomedical applications.